Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for KRISTALLINE FORMEN EINES ANDROGENREZEPTORMODULATORS
Details for 2019169275
Up to date per 09.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2019169275
Title / Product Name
KRISTALLINE FORMEN EINES ANDROGENREZEPTORMODULATORS
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2019169275
EP Publication Number
3533792
E-Number
1389688
Language
EN
PCT Number
Publication Date
04.09.2019 A
05.05.2021 B1
Registration Date
05.05.2021
AT Publication Date
15.05.2021
Application Date
04.06.2013
Registration Number
-
Priorities
07.06.2012
US
201261656888 P
IPC
C07D 401/04 20060101AFI20190527BHEP
Maximum Duration of Protection
04.06.2033
Owner
Aragon Pharmaceuticals, Inc.
10990 Wilshire Blvd. Suite 440
Los Angeles, CA 90024
US
Sloan Kettering Institute For Cancer Research
1275 York Avenue
New York, NY 10065
US
Representative
Representative
Haffner & Keschmann Patentanwälte GmbH
Schottengasse 3a
1010 Wien
AT
Inventor
DILHAS, Anna
Häsingerstr. 32
4055 Basel
CH
OUERFELLI, Ouathek
2077 Center Avenue, Apt. 3J
Fort Lee, NJ 07024
US
SMITH, Nicholas D.
1204 Beryl Street
San Diego, CA 92109
US
HERBERT, Mark R.
4180 Amoroso Street
San Diego, CA 92111
US
Information about Fees
Click here to load the fees